Expression of basic fibroblast growth factor (bFGF), FGF receptor 1 and FGF receptor 2 in uterine leiomyomas and myometrium during the menstrual cycle, after menopause and GnRHa treatment

References

• Kawaguchi K, Fujii S, Konishi I et al. Ultrastructural study of cultured smooth muscle cells from uterine leiomyomas and myometrium under the influence of sex steroids. Gynecol Oncol 1985; 21: 34–41.
   Google Scholar
• Vollenhoven BJ, Lawrence AS, Healy DL. Uterine fibroids: A clinical review. Br J Obstet Gynaecol 1990; 97: 285–98.
   Google Scholar
• Werner R. Mechanisms of angiogenesis. Nature 1997; 386: 671–4.
   Google Scholar
• Dickson RB, Lippman ME. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 1987; 8: 29–43.
   Google Scholar
• Pekonen F, Partanen S, Makinen T. Receptors for epidermal growth factor and insulin-like growth factor 1 and their relation to steroid receptors in human breast cancer. Cancer Res 1988; 48: 1343–7.
   Google Scholar
• Ferenczy A, Richart RM, Okagaki T. A comparative ultrastructural study of leiomyosarcoma, cellular leiomyomas and leiomyoma of the uterus. Cancer 1971; 28: 1004–8.
   Google Scholar
• Geospodarowicz D, Ferrara N, Schweigerer L et al. Structural characterization and biological functions of FGF. En- docr Rev 1987; 8: 95–114.
   Google Scholar
• Folkman J, Klagsbrun M. Angiogenic factors. Science 1987; 235: 442–7.
   Google Scholar
• Rifkin DB, Moscatelli D. Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 1989; 109: 1–6.
   Google Scholar
• Rusnati M, Casarotti G, Pecorelli S et al. Basic fibroblast growth factor in ovulatory cycle and postmenopausal human endometrium. Growth Factors 1990; 3: 299–307.
   Google Scholar
• Salat-Baroux J, Romain S, Alvarez S et al. Biochemical and immunohistochemical multiparametric analysis of steroid receptors and growth factor receptors in human normal endometrium in spontaneous cycles and after the induction of ovulation. Hum Reprod 1994; 9: 200–8.
   Google Scholar
• Mangrulkar RS, Ono M, Ishikawa M et al. Isolation and characterization of heparin-binding growth factors in human leiomyomas and normal myometrium. Biol Reprod 1995; 53: 636–46.
   Google Scholar
• Anania CA, Stewart EA, Quade BJ et al. Expression of the fibroblast growth factor receptor in women with leiomyomas and abnormal uterine bleeding. Mol Hum Reprod 1997; 3: 685–91.
   Google Scholar
• Dixon D, He H, Haseman JK. Immunohistochemical localization of growth factors and their receptors in uterine leiomyomas and matched myometrium. Environ Health Per- spect 2000; 108 (Suppl 5): 795–802.
   Google Scholar
• Cordon-Cardo C, Vlodavsky I, Haimovitz-Friedman A et al. Expression of basic fibroblast growth factor in normal human tissues. Lab Invest 1990; 63: 832–40.
   Google Scholar
• Weich HA, Iberg N, Klagsbrun M et al. Expression of acidic and basic FGF in human and bovine vascular smooth muscle cells. Growth Factors 1990; 2: 313–20.
   Google Scholar
• Casscells W, Speir E, Sasse L et al. Isolation characterization and localization of heparin-binding growth factors in the heart. J Clin Invest 1990; 85: 433–41.
   Google Scholar
• Linda CG. The implanting conceptus and its maternal host. Organon’s magazine on women and health 1997; 3: 48–51.
   Google Scholar
• Presta M, Maier JAM, Rusnati M et al. Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor beta. Cancer Res 1988; 48: 6384–9.
   Google Scholar
• Rider V, Carlone DL, Foster RT. Oestrogen and progesterone control basic fibroblast growth factor mRNA in the rat uterus. J Endocrinol 1997; 154: 75–84.
   Google Scholar
• Kneifer MA, Leytus SP, Fletcher E et al. Uterine plasminogen activator activity: modulation by steroid hormones. Endocrinology 1982; 111: 493–9.
   Google Scholar
• Saksela O, Rifkin DB. Release of basic fibroblast growth factor-heparin sulfate complexes from endothelial cells by plasminogen activator-mediated proteolytic activity. J Cell Biol 1990; 110: 767–75.
   Google Scholar
• Friedman AJ. Treatment of uterine myomas with GnRH agonists. Semin Reprod Endocrinol 1993; 11: 154–61.
   Google Scholar
• Rein MS, Nowak RA. Biology of uterine myomas and myometrium in vitro. Semin Reprod Endocrinol 1992; 10: 310–19.
   Google Scholar
• Mizutani T, Sugihara A, Nakamuro K, Terada N. Suppression of cell proliferation and induction of apoptosis in uterine leiomyoma by gonadotropin-releasing hormone agonist (Leuprolide Acetate). J Clin Endocrinol Metab 1998; 83: 1253–5.
   Google Scholar
• Howe SR, Gottardis MM, Everitt JI et al. Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo. Endocrinology 1995; 136: 4996–5003.
   Google Scholar
• D’Amore PA, Brown RH, Ku RT et al. Elevated basic fibroblast growth factor serum levels of patients with Duchenne’s muscular dystrophy. Ann Neurol 1994; 35: 362–5.
   Google Scholar
• Brodsky W Uryvaeva IV Cell polyploidy: its relation to tissue growth and function. Int Rev Cytol 1977; 50: 275–332.
   Google Scholar
• Herbert AW, Niggi I, Michael K et al. Expression of acidic and basic fibroblast growth factors in human and bovine vascular smooth muscle cells. Growth Factors 1990; 2: 313–20.
   Google Scholar
• Flaumenhaft R, Moscatelli D, Saksela O et al. Role of extracellular matrix in the action of basic fibroblast growth factor: matrix as a source of growth factor for long-term stimulation of plasminogen activator production and DNA synthesis. J Cell Physiol 1989; 140: 75–81.
   Google Scholar
• Demopoulos RI, Jones KY, Mittal KR et al. Histology of leiomyomata in patients treated with leuprolide acetate. Int J Gynecol Pathol 1997; 16: 131–7.
   Google Scholar
• Rutgers JL, Spong CY, Sinow R et al. Leuprolide acetate treatment and myoma arterial size. Obstet Gynecol 1995; 86: 386–8.
   Google Scholar
• Mannion JD, Blood V Bailey W et al. The effect of basic fibroblast growth factor on the blood flow and morphologic features of a latissimus dorsi cardiomyoplasty. J Thor- ac Cardiovasc Surg 1996; 111: 19–28.
   Google Scholar
• Iannaccone S, Quattrini A, Smirne S et al. Connective tissue proliferation and growth factors in animal models of Duchenne muscular dystrophy. J Neurol Sci 1995; 128: 36–44.
   Google Scholar
• Rauk PN, Surti U, Roberts JM et al. Mitogenic effect of basic fibroblast growth factor and estradiol on cultured human myometrial and leiomyoma cells. Am J Obstet Gynecol 1995; 173: 571–7.
   Google Scholar
• Piva M, Flieger O, Rider V. Growth factor control of cultured rat uterine stromal cell proliferation is progesterone dependent. Biol Reprod 1996; 55: 1333–42.
   Google Scholar
• Luqmani Y, Graham M, Coombes RC. Expression of bFGF, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 1992; 66: 273–80.
   Google Scholar
• Blanckaert VD, Hebbar M, Louchez MM et al. Basic fibroblast growth factor receptors and their prognostic value in human breast cancer. Clin Cancer Res 1998; 4: 2939–47.
   Google Scholar
• Matsubara A, Kan M, Feng SJ et al. Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res 1998; 58: 1509–14.
   Google Scholar
• Feng S, Wang F, Matsubara A et al. Fibroblast growth factor receptor 2 limits and receptor 1 accelerates tumorigenic- ity of prostate epithelial cells. Cancer Res 1997; 57: 5369–78.
   Google Scholar
• Pekonen F, Nyman T, Rutanen EM. Differential expression of keratinocyte growth factor and its receptor in the human uterus. Mol Cell Endocrinol 1993; 95: 43–9.
   Google Scholar
• Sari S, Fredrika P, Tuulikki N et al. Distinct patterns of expression of keratinocyte growth factor and its receptor in endometrial carcinoma. Cancer 1997; 79: 1166–71.
   Google Scholar
• Ishiwata T, Friess H, Buchler MW et al. Characterization of keratinocyte growth factor and receptor expression in human pancreatic cancer. Am J Pathol 1998; 153: 213–22.
   Google Scholar